CommercialCoverageMedium impact
Medical Policy Update
Blue Cross Blue Shield of Kansas·KS · Oncology, Hematology, Cardiology +2 more·Medical Policy
Effective date
Jan 10, 2023
We identified it
Jun 19, 2026
Summary
Blue Cross Blue Shield of Kansas published updates to four medical policies on 01/10/23 covering genetic testing for breast cancer, biomarker testing for lung cancer, aortic valve procedures, and gene therapy. Providers should review the full policy details to understand any changes to coverage criteria or requirements.
Action Required
Review the four updated BCBSKS medical policies published on 01/10/23 for: genetic expression assays in breast cancer, biomarker testing in lung cancer, transcatheter aortic valve implantation, and Zolgensma gene therapy. Contact BCBSKS provider consultant if clarification is needed on coverage changes or billing requirements.